Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling

References

• Kim GH, Min YW, Lee H, et al. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. PLoS One. 2020;15(9):e0238113.
   PubMed Web of Science ®Google Scholar
• Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014 May 1;509(7498):91–95.
   PubMed Web of Science ®Google Scholar
• Hamai Y, Emi M, Ibuki Y, et al. Distribution of lymph node metastasis in esophageal squamous cell carcinoma after trimodal therapy. Ann Surg Oncol. 2021 Mar;28(3):1798–1807.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017 Jul 27;3:17048.
   PubMed Web of Science ®Google Scholar
• Rodvold JJ, Zanetti M. Tumor microenvironment on the move and the Aselli connection. Sci Signal. 2016 Jun 28;9(434):fs13.
   PubMed Web of Science ®Google Scholar
• Zeestraten EC, Van Hoesel AQ, Speetjens FM, et al. FoxP3- and CD8-positive infiltrating immune cells together determine clinical outcome in colorectal cancer. Cancer Microenviron. 2013 Apr;6(1):31–39.
   PubMedGoogle Scholar
• Minami K, Hiwatashi K, Ueno S, et al. Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma. Exp Ther Med. 2018 May;15(5):4465–4476.
   PubMed Web of Science ®Google Scholar
• Taylor ES, McCall JL, Shen S, et al. Prognostic roles for IL-2-producing and CD69(+) T cell subsets in colorectal cancer patients. Int J Cancer. 2018 Oct 15;143(8):2008–2016.
   PubMed Web of Science ®Google Scholar
• Fiori ME, Di Franco S, Villanova L, et al. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019 Mar 30;18(1):70.
   PubMed Web of Science ®Google Scholar
• Shintani Y, Fujiwara A, Kimura T, et al. IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling. J Thorac Oncol. 2016 Sep;11(9):1482–1492.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Noma K, Ohara T, et al. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma. Cancer Biol Ther. 2019;20(9):1234–1248.
   PubMed Web of Science ®Google Scholar
• Maehara O, Suda G, Natsuizaka M, et al. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis. 2017 Oct 26;38(11):1073–1083.
   PubMed Web of Science ®Google Scholar
• Nurmik M, Ullmann P, Rodriguez F, et al. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer. 2020 Feb 15;146(4):895–905.
   PubMed Web of Science ®Google Scholar
• Zhang H, Hua Y, Jiang Z, et al. Cancer-associated fibroblast-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. 2019 Mar 15;25(6):1989–2000.
   PubMed Web of Science ®Google Scholar
• Yang F, Ning Z, Ma L, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer. 2017 Aug 29;16(1):148.
   PubMed Web of Science ®Google Scholar
• Davies AE, Albeck JG. Microenvironmental signals and biochemical information processing: cooperative determinants of intratumoral plasticity and heterogeneity. Front Cell Dev Biol. 2018;6:44.
   PubMed Web of Science ®Google Scholar
• Alipoor SD, Mortaz E, Varahram M, et al. The potential biomarkers and immunological effects of tumor-derived exosomes in lung cancer. Front Immunol. 2018;9:819.
   PubMed Web of Science ®Google Scholar
• Khushman M, Bhardwaj A, Patel GK, et al. Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens. Pancreas. 2017 Jul;46(6):782–788.
   PubMed Web of Science ®Google Scholar
• Durrieu L, Bharadwaj A, Waisman DM. Analysis of the thrombotic and fibrinolytic activities of tumor cell-derived extracellular vesicles. Blood Adv. 2018 May 22;2(10):1054–1065.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu Y, Xiu F, et al. Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses. Int J Nanomedicine. 2018;13:467–477.
   PubMed Web of Science ®Google Scholar
• Takano Y, Masuda T, Iinuma H, et al. Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer. Oncotarget. 2017 Oct 3;8(45):78598–78613.
   PubMedGoogle Scholar
• Yamada N, Kuranaga Y, Kumazaki M, et al. Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression. Oncotarget. 2016 May 10;7(19):27033–27043.
   PubMedGoogle Scholar
• Wang XM, Liu XM, Wang Y, et al. Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway. Bioengineered. 2021 Dec;12(1):117–126.
   PubMed Web of Science ®Google Scholar
• Tong Y, Yang L, Yu C, et al. Tumor-secreted exosomal lncRNA POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast differentiation into CAFs. Mol Ther Oncolytics. 2020 Sep 25;18:1–13.
   PubMed Web of Science ®Google Scholar
• Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948.
   PubMed Web of Science ®Google Scholar
• Qin X, Guo H, Wang X, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol. 2019 Jan 14;20(1):12.
   PubMed Web of Science ®Google Scholar
• Yan S, Xu J, Liu B, et al. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway. Bioengineered. 2021 Dec;12(1):682–696.
   PubMed Web of Science ®Google Scholar
• Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020 Dec;11(1):70–80.
   PubMed Web of Science ®Google Scholar
• Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020 Dec;11(1):718–728.
   PubMed Web of Science ®Google Scholar
• Shifrin DA Jr., Demory Beckler M, Coffey RJ, et al. Extracellular vesicles: communication, coercion, and conditioning. Mol Biol Cell. 2013 May;24(9):1253–1259.
   PubMed Web of Science ®Google Scholar
• Zhao G, Li H, Guo Q, et al. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Cancer Med. 2020 Apr;9(7):2500–2513.
   PubMed Web of Science ®Google Scholar
• Bhome R, Goh RW, Bullock MD, et al. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. Aging (Albany NY). 2017 Dec 28;9(12):2666–2694.
   PubMedGoogle Scholar
• Tan D, Li G, Zhang P, et al. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells. Bioengineered. 2022 Jan;13(1):1838–1857.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang W, Zhuo H, et al. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. Bioengineered. 2022 Mar;13(3):4786–4797.
   PubMed Web of Science ®Google Scholar
• Shou Y, Wang X, Liang Y, et al. Exosomes-derived miR-154-5p attenuates esophageal squamous cell carcinoma progression and angiogenesis by targeting kinesin family member 14. Bioengineered. 2022 Feb;13(2):4610–4620.
   PubMed Web of Science ®Google Scholar
• Li Y, Lu J, Bai F, et al. Ginsenoside Rg3 suppresses proliferation and induces apoptosis in human osteosarcoma. Biomed Res Int. 2018;2018:4306579.
   PubMed Web of Science ®Google Scholar
• Domankevich V, Efrati M, Schmidt M, et al. RIG-1-like receptor activation synergizes with intratumoral alpha radiation to induce pancreatic tumor rejection, triple-negative breast metastases clearance, and antitumor immune memory in mice. Front Oncol. 2020;10:990.
   PubMed Web of Science ®Google Scholar
• Huang B, Li J, Zhang X, et al. RIG-1 and MDA-5 signaling pathways contribute to IFN-β production and viral replication in porcine circovirus virus type 2-infected PK-15 cells in vitro. Vet Microbiol. 2017 Nov;211:36–42.
   PubMed Web of Science ®Google Scholar
• Song B, Ji W, Guo S, et al. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. FEBS Lett. 2014 Nov 28;588(23):4375–4381.
   PubMed Web of Science ®Google Scholar
• Hou J, Zhou Y, Zheng Y, et al. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell. 2014 Jan 13;25(1):49–63.
   PubMed Web of Science ®Google Scholar
• Peng D, Chen L, Sun Y, et al. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling. Biomed Pharmacother. 2020 May;125:109984.
   PubMed Web of Science ®Google Scholar
• Wolf D, Fiegl H, Zeimet AG, et al. High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome. Int J Cancer. 2020 Apr 1;146(7):2007–2018.
   PubMed Web of Science ®Google Scholar
• Jing D, Zhou W, Shen L, et al. RIG-I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma. Cancer Med. 2019 Oct;8(14):6344–6357.
   PubMed Web of Science ®Google Scholar